Adaptive Phage Therapeutics, Inc. — Form D

Adaptive Phage Therapeutics, Inc. of GAITHERSBURG, MD, a company, filed a Form D exempt-offering notice with the SEC on 2017-04-14. The offering totals $3.0M, of which $765K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Gregory MerrilDirectorNess Ziona, L3
Gregory MerrilExecutive OfficerNess Ziona, L3
Jonathan L LeffDirectorGaithersburg, MD
Jana L JensenDirectorGaithersburg, MD
Carl R MerrilDirectorGaithersburg, MD
Carl R MerrilExecutive OfficerGaithersburg, MD
Ian L HardyDirectorGaithersburg, MD
Michael L OrndorffExecutive OfficerGaithersburg, MD
Gregory L MerrilDirectorGaithersburg, MD
Gregory L MerrilExecutive OfficerGaithersburg, MD
Gregory L MerrilPromoterGaithersburg, MD
Jesse L GoodmanDirectorGaithersburg, MD
Raymond L MartzDirectorGaithersburg, MD
Martin L HeideckerDirectorGaithersburg, MD
Evan L LohDirectorGaithersburg, MD
Subhendu L BasuExecutive OfficerGaithersburg, MD
Subhendu Louis BasuExecutive OfficerGaithersburg, MD
Gregory Louis MerrilDirectorGaithersburg, MD
Gregory Louis MerrilExecutive OfficerGaithersburg, MD
Carl Louis MerrilDirectorGaithersburg, MD
Carl Louis MerrilExecutive OfficerGaithersburg, MD
Raymond Louis MartzDirectorGaithersburg, MD
William Louis MutrynDirectorGaithersburg, MD

Other filings by this issuer (7)

FiledFormOfferingSold
2023-06-09D$30.0M$12.0M
2021-05-20D$53.3M$23.3M
2020-08-27D/A$3.6M
2020-08-24D$7.0M$3.4M
2020-06-22D$7.0M$2.8M
2019-11-27D/A$7.0M$7.0M
2018-06-05D$5.0M$2.4M

More